Figure S7 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G<sub>1</sub>–S Transition

Stefan A.J. Buck,Annelies Van Hemelryk, Corrina de Ridder,Debra Stuurman, Sigrun Erkens-Schulze, Sem van ’t Geloof, Wilma J. Teubel,Stijn L.W. Koolen,Elena S. Martens-Uzunova,Martin E. van Royen,Ronald de Wit,Ron H.J. Mathijssen,Wytske M. van Weerden

crossref（2024）

引用 0|浏览2

暂无评分

摘要

Ki-67 staining of PC346C PDX tumor samples. Ki-67 staining of PC346C PDX tumors after eight days of treatment with darolutamide or vehicle and an i.v. injection of docetaxel or vehicle at day five. (n=4 per group, except for vehicle/vehicle with n=3)

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Figure S7 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G&lt;sub&gt;1&lt;/sub&gt;–S Transition

Figure S7 from Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G<sub>1</sub>–S Transition